Phase II Study of JNS024ER in Japanese Subjects With Chronic Pain Due to Osteoarthritis of the Knee or Low Back Pain
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2016
At a glance
- Drugs Tapentadol (Primary)
- Indications Back pain; Osteoarthritis; Pain
- Focus Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 20 Mar 2012 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 27 Jan 2011 Actual patient number changed from 88 to 91 according to ClinicalTrials.gov.
- 27 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.